Article content material
Canadian generic drug producer Apotex Inc. is planning for a possible preliminary public providing subsequent 12 months, in line with folks conversant in the matter.
RBC Capital Markets LLC, Jefferies Financial Group Inc. and TD Securities Inc. are advisors for the deal, the folks stated, asking to not be recognized discussing data that’s nonetheless non-public. No choices have been made but on actual timing or dimension, and extra banks could also be added to the lineup later, they stated.
Spokespeople for TD and Jefferies declined to remark. Spokespeople for RBC and Apotex didn’t instantly reply to requests for remark.
Apotex, based mostly in Toronto, was based in 1974 by Barry Sherman, who constructed it into one of many world’s largest makers of generic medicine. Sherman and his spouse, Honey Sherman, have been discovered lifeless of their Toronto dwelling in December 2017 in what police stated was a double murder.
With a internet price of about $3.6 billion on the time of their deaths, they ranked as two of the wealthiest folks on the earth ever to be murdered, and the crime stays unsolved virtually seven years later.
Apotex was bought to New York-based non-public fairness agency SK Capital Partners LP in a deal that closed in 2023. The sale valued the corporate at between $3 billion and $4 billion, folks with data of the transaction informed Bloomberg Businessweek final 12 months.
-
Murdered billionaire Sherman’s Apotex bought to personal agency
-
Murdered Sherman billionaire’s household break up by lawsuit over cash
A spokesperson for SK Capital didn’t reply to questions from Bloomberg News.
Earlier this 12 months, Apotex purchased Montreal-based Searchlight Pharma Inc., a specialty health-care firm that focuses on promoting patented remedy specializing in ladies’s well being, dermatology, allergy, ache administration and hospital specialty markets.
Share this text in your social community
